DGB was founded in 2020 by a group of investors and scientists. The group is dedicated to provide IVD industry with basic products they need a high quality.

Quality assurance and control has been a major concern ever since the company was founded.

We are performing continuous R&D to develop new products and simultaneously improve our current products in collaboration with our partners.

Our team expertise and experience consists of a variety of fields, including immunology, medical biotechnology, cellular biology, beside investment and management experiences.